FI68244C - Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav Download PDF

Info

Publication number
FI68244C
FI68244C FI793001A FI793001A FI68244C FI 68244 C FI68244 C FI 68244C FI 793001 A FI793001 A FI 793001A FI 793001 A FI793001 A FI 793001A FI 68244 C FI68244 C FI 68244C
Authority
FI
Finland
Prior art keywords
leu
arg
boc
formula
compound
Prior art date
Application number
FI793001A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI793001A (fi
FI68244B (fi
Inventor
Hans Kofod
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of FI793001A publication Critical patent/FI793001A/fi
Application granted granted Critical
Publication of FI68244B publication Critical patent/FI68244B/fi
Publication of FI68244C publication Critical patent/FI68244C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/645—Secretins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI793001A 1978-09-28 1979-09-26 Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav FI68244C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK430478 1978-09-28
DK430478 1978-09-28

Publications (3)

Publication Number Publication Date
FI793001A FI793001A (fi) 1980-03-29
FI68244B FI68244B (fi) 1985-04-30
FI68244C true FI68244C (fi) 1985-08-12

Family

ID=8132257

Family Applications (2)

Application Number Title Priority Date Filing Date
FI793001A FI68244C (fi) 1978-09-28 1979-09-26 Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav
FI793002A FI68245C (fi) 1978-09-28 1979-09-26 Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI793002A FI68245C (fi) 1978-09-28 1979-09-26 Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav

Country Status (16)

Country Link
US (1) US4356119A (nl)
JP (2) JPS5576849A (nl)
AT (1) AT375338B (nl)
AU (2) AU533684B2 (nl)
BE (2) BE879086A (nl)
CA (2) CA1140116A (nl)
CH (2) CH648567A5 (nl)
DE (2) DE2939135A1 (nl)
ES (2) ES484926A1 (nl)
FI (2) FI68244C (nl)
FR (2) FR2437400A1 (nl)
GB (2) GB2031436B (nl)
IT (2) IT1125422B (nl)
NL (2) NL7907187A (nl)
NO (2) NO148923C (nl)
SE (2) SE7907938L (nl)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA798855A (en) * 1968-11-12 Bernardi Luigi Process for preparing a new undecapeptide
CA685075A (en) * 1964-04-21 Schwyzer Robert Polypeptides and process for their manufacture
CA616330A (en) * 1961-03-14 Schwyzer Robert Polypeptide and derivatives thereof and process for their manfuacture
GB1064417A (en) * 1963-12-09 1967-04-05 Kyowa Hakko Kogyo Kk Process for the preparation of copolypeptides
US3400118A (en) * 1966-05-27 1968-09-03 Squibb & Sons Inc Intermediates in the preparation of secretin
US3832337A (en) * 1970-07-28 1974-08-27 Squibb & Sons Inc Peptide enzyme inhibitors
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175988C (nl) * 1972-05-24 1985-02-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2315271C3 (de) * 1973-03-27 1975-09-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4110321A (en) * 1976-07-12 1978-08-29 Folkers Karl Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity
US4086220A (en) * 1976-08-09 1978-04-25 G. D. Searle & Co. Fragments of secretin

Also Published As

Publication number Publication date
NO793112L (no) 1980-03-31
JPS5576849A (en) 1980-06-10
AU526149B2 (en) 1982-12-16
BE879086A (fr) 1980-03-28
JPS5569550A (en) 1980-05-26
CH648568A5 (de) 1985-03-29
AU533684B2 (en) 1983-12-08
DE2939135A1 (de) 1980-04-17
DE2939109A1 (de) 1980-04-10
FI793001A (fi) 1980-03-29
SE7907939L (sv) 1980-03-29
GB2031436B (en) 1982-10-20
BE879087A (fr) 1980-03-28
AU5124579A (en) 1980-04-03
GB2031436A (en) 1980-04-23
IT7926112A0 (it) 1979-09-28
FI793002A (fi) 1980-03-29
IT1125421B (it) 1986-05-14
FR2437400B1 (nl) 1984-06-15
ES484928A1 (es) 1980-07-01
AU5124679A (en) 1980-04-03
FR2437400A1 (fr) 1980-04-25
NO148923C (no) 1984-01-11
SE7907938L (sv) 1980-03-29
GB2031435B (en) 1982-11-10
NO793111L (no) 1980-03-31
CA1158640A (en) 1983-12-13
FI68244B (fi) 1985-04-30
ES484926A1 (es) 1980-07-01
IT1125422B (it) 1986-05-14
NL7907188A (nl) 1980-04-01
IT7926111A0 (it) 1979-09-28
AT375338B (de) 1984-07-25
FI68245B (fi) 1985-04-30
GB2031435A (en) 1980-04-23
CH648567A5 (de) 1985-03-29
NO148923B (no) 1983-10-03
FR2437399A1 (fr) 1980-04-25
CA1140116A (en) 1983-01-25
NL7907187A (nl) 1980-04-01
FI68245C (fi) 1985-08-12
ATA634679A (de) 1983-12-15
NO148922C (no) 1984-01-11
NO148922B (no) 1983-10-03
US4356119A (en) 1982-10-26
FR2437399B1 (nl) 1983-01-28

Similar Documents

Publication Publication Date Title
EP0830372B1 (en) Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
US20110160431A1 (en) Production of peptides containing poly-gly sequences using fmoc chemistry
US5492892A (en) Endothelin antagonists
CN111378028A (zh) 酰化glp-1化合物及其修饰基团的合成
US20170152289A1 (en) Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
EP1997826A2 (en) Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them
FI68244C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva polypeptidderivat eller syraadditionssalter daerav
US5786335A (en) Sulfhydryl containing peptides for treating vascular disease
CN113583088A (zh) 用于治疗胃癌的环肽及其药物组合物
CN116693622A (zh) 基于Ascaphin的芳香硫醚订书肽类抗肿瘤活性化合物、制备方法及应用
WO1991001976A1 (en) Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same
US6316413B1 (en) Peptide agonists of bradykinin B2 receptor
CN112062828B (zh) Fgf-5多肽抑制剂及其生发应用
KHAN et al. SYNTHESIS OF THE DODECAPEPTIDE‐α MATING FACTOR OF SACCHAROMYCES CEREVISIAE
US4265884A (en) Therapeutically active polypeptides or acid addition salts thereof and a process for producing such compounds
Meienhofer et al. Solid-phase synthesis with attachment of peptide to resin through an amino acid side chain:[8-lysine]-vasopressin
JP7196113B2 (ja) ペプチド系化合物、その応用及びそれを含む組成物
RU2458066C1 (ru) Способ получения пептида эксенатида
Schafer et al. Amino-acids and peptides. Part XXXII. A simplified synthesis of bradykinin by use of the picolyl ester method
JP2782232B2 (ja) プロテアーゼ阻害剤
JPH07316193A (ja) ペプチド誘導体およびその用途
JPH04501710A (ja) 新規なペンタペプチドおよびその製造方法
DK145715B (da) Fremgangsmaade til fremstilling af peptider ved kobling ved hjaelp af en aktiv ester og under tilsaetning af en n-heterocyclisk katalysator
CN117645651A (zh) 一种环肽类抗肿瘤活性化合物及药物组合物与应用
AU651557C (en) Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: NORDISK INSULINLABORATORIUM